Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shameen Afif-Rider"'
Autor:
Arnaud C. Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari, Mahammad Ahmed, Raul Pardo, John Bingham, Lauren Adams, Kathleen Santos, Gyoung-Dong Kang, Kathryn M. Pugh, Shameen Afif-Rider, Kapil Vashisht, Kemal Haque, Ravinder Tammali, Edward Rosfjord, Adriana Savoca, John A. Hartley, Philip W. Howard
Publikováno v:
Molecular Cancer Therapeutics. 22:254-263
Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA crosslinkers are currently being evaluated in clinical trials with encouraging results in Hodgkin and non-Hodgkin lymphomas. The first example of an ADC delivering a PBD DNA c
Autor:
Philip W. Howard, John A. Hartley, Mary McFarlane, Luke A. Masterson, Kathryn Ball, Conor S. Barry, Lauren Adams, Rhiannon Beard, K. Phin Chooi, Gyoung-Dong Kang, Ian Hutchinson, Jitka Riedl, Kathleen Santos, Balakumar Vijayakrishnan, Shameen Afif-Rider, Neki Patel, Kathryn Pugh, Stephen J. Gregson
Supplementary Data from Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0808e71ffb8fdea67b4acfbd119e387a
https://doi.org/10.1158/1535-7163.22523461.v1
https://doi.org/10.1158/1535-7163.22523461.v1
Autor:
Philip W. Howard, John A. Hartley, Adriana Savoca, Edward Rosfjord, Ravinder Tammali, Kemal Haque, Kapil Vashisht, Shameen Afif-Rider, Kathryn M. Pugh, Gyoung-Dong Kang, Kathleen Santos, Lauren Adams, John Bingham, Raul Pardo, Mahammad Ahmed, Arman Esfandiari, Balakumar Vijayakrishnan, Arnaud C. Tiberghien
Antibody–drug conjugates (ADC) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers are currently being evaluated in clinical trials, with encouraging results in Hodgkin and non–Hodgkin lymphomas. The first example of an ADC delivering a PBD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8488a0a00b384b17e9155a0ccd41cbca
https://doi.org/10.1158/1535-7163.c.6543561.v1
https://doi.org/10.1158/1535-7163.c.6543561.v1
Autor:
Philip W. Howard, John A. Hartley, Adriana Savoca, Edward Rosfjord, Ravinder Tammali, Kemal Haque, Kapil Vashisht, Shameen Afif-Rider, Kathryn M. Pugh, Gyoung-Dong Kang, Kathleen Santos, Lauren Adams, John Bingham, Raul Pardo, Mahammad Ahmed, Arman Esfandiari, Balakumar Vijayakrishnan, Arnaud C. Tiberghien
Supplementary information to support article findings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a073b52ec26cb776d960aebc3a5a5aa
https://doi.org/10.1158/1535-7163.22523031.v1
https://doi.org/10.1158/1535-7163.22523031.v1
Autor:
Rakesh Dixit, Nazzareno Dimasi, Phillip W. Howard, Arnaud Tiberghien, Luke Masterson, Cui Chen, Neki Patel, Shannon Breen, Patricia C. Ryan, Molly Reed, Marlon Rebelatto, Kapil Vashisht, Binyam Bezabeh, Jay Harper, Haihong Zhong, Michele Gunsior, Xiang Qing Yu, Shameen Afif-Rider, Bo Zheng, Pauline M. Ryan, Mary Jane Masson Hinrichs
Purpose: To use preclinical models to identify a dosing schedule that improves tolerability of highly potent pyrrolobenzodiazepine dimers (PBDs) antibody drug conjugates (ADCs) without compromising antitumor activity.Experimental Design: A series of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09bff01a2c0da935c0ea2819fe0a9ef9
https://doi.org/10.1158/1078-0432.c.6526344
https://doi.org/10.1158/1078-0432.c.6526344
Autor:
Rakesh Dixit, Nazzareno Dimasi, Phillip W. Howard, Arnaud Tiberghien, Luke Masterson, Cui Chen, Neki Patel, Shannon Breen, Patricia C. Ryan, Molly Reed, Marlon Rebelatto, Kapil Vashisht, Binyam Bezabeh, Jay Harper, Haihong Zhong, Michele Gunsior, Xiang Qing Yu, Shameen Afif-Rider, Bo Zheng, Pauline M. Ryan, Mary Jane Masson Hinrichs
Supplementary Figure 1. (a,b) Structure of the payloads SG3249 and SG3400; Supplementary Figure 2. PK concentration vs. time profile of R347-SG3400 in monkeys after either a single IV injection of 4.5mg/kg or 3 weekly IV injections of 1.5mg/kg; Suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18262bd2056388988e5e07e301278edb
https://doi.org/10.1158/1078-0432.22466538
https://doi.org/10.1158/1078-0432.22466538
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 123
Autor:
Erin Straley, Shameen Afif-Rider
Publikováno v:
Lab animal. 48(9)
Autor:
Arnaud C. Tiberghien, Howard Phillip Wilson, Xiang Qing Yu, Binyam Bezabeh, Michele Gunsior, Molly Reed, Mary Jane Hinrichs, Jay Harper, Rakesh Dixit, Luke Masterson, Patricia C. Ryan, Kapil Vashisht, Shameen Afif-Rider, Marlon Rebelatto, Bo Zheng, Neki V. Patel, Haihong Zhong, Nazzareno Dimasi, Cui Chen, Shannon Breen, Pauline M. Ryan
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(19)
Purpose: To use preclinical models to identify a dosing schedule that improves tolerability of highly potent pyrrolobenzodiazepine dimers (PBDs) antibody drug conjugates (ADCs) without compromising antitumor activity.Experimental Design: A series of
Publikováno v:
Lab animal. 41(5)